Cerebral ischemic disease often causes morbidity and mortality, while the i
nduction of new blood vessels is expected to provide a therapeutic effect i
n this occlusive cerebrovascular disease. In this study, we utilized two re
plication-deficient adenoviral vectors containing cDNA from basic fibroblas
t growth factor (bFGF), a well-known angiogenic factor, and examined whethe
r biological angiogenic activity of adenovirally gene-transferred bFGF coul
d be observed in the rat brain. One vector contained native cDNA from bFGF
without the secretory signal sequence and the other contained the same cDNA
fused with an interleukin-2 secretory signal sequence. After ventricular a
dministration of these viral vectors, gene-transferred cells demonstrated a
high immunoreactivity against the anti-bFGF antibody and a remarkably high
concentration of bFGF was detected in the cerebrospinal fluid. A semiquant
itative analysis of angiogenic activity revealed that bFGF gene transfer in
duced angiogenesis in normal rat brains, with a more pronounced angiogenic
effect seen with the vector of a secreted form than with the vector without
a secretory signal sequence. These results suggest that bFGF gene transfer
using these adenoviral vectors might be useful for the treatment of ischem
ic cerebrovascular disease.